Bioxytran (BIXT) Selling, General & Administrative (2010 - 2026)
Bioxytran (BIXT) reported Selling, General & Administrative of $189,121 for Q2 2026, up 100.1% from $94,529 a year earlier but down 11.6% from the prior quarter.
Powered by 
Analysis
Bioxytran (BIXT) Selling, General & Administrative (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Bioxytran's Selling, General & Administrative came in at $798,025, up 29.4% year-over-year; for FY2025, it was $648,229, down 44.5% from FY2024.
- Selling, General & Administrative has a five-year compound annual growth rate of 6.4% (FY2020 to FY2025).
- By year, Selling, General & Administrative came in at $1.17 million in FY2024 (-16.8%), $1.4 million in FY2023 (+68.1%), $834,679 in FY2022 (-48.2%) and $1.61 million in FY2021 (+238.6%).
- Five-year quarterly Selling, General & Administrative spans a low of -$563,604 in Q3 2022 and a high of $604,932 in Q2 2023.
- Year over year, Selling, General & Administrative has now increased in each of the last four quarters, with an average decline of 8.3% over the last eight quarters.
- The high point for year-over-year Selling, General & Administrative in five years was Q3 2021 (growth of 246.3%); the low point was Q2 2025 (a decline of 78.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $213,974 (Q1 2026), $235,799 (Q4 2025) and $159,131 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 6.43 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.63 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.90 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -3.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -5.65 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.75 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.92 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 3.41 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 582.20 Mn |
| 10 | Bioxytran | 2.29 Mn | 1.13 Mn | - | 189,121.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 189,121.00 |
| Mar 31, 2026 | 213,974.00 |
| Dec 31, 2025 | 235,799.00 |
| Sep 30, 2025 | 159,131.00 |
| Jun 30, 2025 | 94,529.00 |
| Mar 31, 2025 | 143,770.00 |
| Dec 31, 2024 | 220,560.00 |
| Sep 30, 2024 | 158,071.00 |
| Jun 30, 2024 | 447,875.00 |
| Mar 31, 2024 | 320,997.00 |
| Dec 31, 2023 | 510,107.00 |
| Sep 30, 2023 | 232,778.00 |
| Jun 30, 2023 | 604,932.00 |
| Mar 31, 2023 | 587,638.00 |
| Dec 31, 2022 | 394,343.00 |
| Sep 30, 2022 | -563,604.00 |
| Jun 30, 2022 | 447,360.00 |
| Mar 31, 2022 | 535,861.00 |
| Dec 31, 2021 | 408,314.00 |
| Sep 30, 2021 | 364,437.00 |
API Access
Bioxytran Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=BIXT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "BIXT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=BIXT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();